Systemic Lupus Erythematosus and Accelerated Aging
Launched by UNIVERSITY HOSPITAL, BORDEAUX · Jan 13, 2023
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the immune system ages in people with Systemic Lupus Erythematosus (SLE), a condition that affects the body's immune system and can cause various health issues. The researchers want to understand if and how aging affects the immune systems of patients with lupus, which could help improve treatments and care for those living with the disease.
To participate in this study, you need to be between 18 and 60 years old and have a confirmed diagnosis of systemic lupus erythematosus. Both men and women are welcome to join. However, pregnant or breastfeeding women, as well as individuals who are unable to give consent due to legal reasons or age restrictions, cannot participate. If you choose to join, you will be asked to sign a consent form, and you can expect to provide information about your health and lupus experience. This study is currently looking for participants, so it's an opportunity to contribute to important research that could benefit many others with lupus.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • male or female;
- • age between 18 and 60 years;
- • Lupus patient : diagnosis of systemic lupus erythematosus according to ACR or SLICC criteria;
- • being affiliated to health insurance;
- • willing to participate and to sign informed consent.
- Exclusion Criteria:
- • pregnant or breastfeeding women;
- • persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent
About University Hospital, Bordeaux
The University Hospital of Bordeaux is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institution integrates cutting-edge scientific inquiry with patient care, fostering an environment that encourages collaboration among multidisciplinary teams. With a commitment to improving treatment outcomes and enhancing patient safety, the University Hospital of Bordeaux plays a pivotal role in the development of new therapies and medical technologies, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bordeaux, France
Patients applied
Trial Officials
Noemie GENSOUS, MD
Principal Investigator
University Hospital, Bordeaux
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials